| CYP2D6*10 genotype was associated with worse outcome of premenopausal breast cancer patients receiving adjuvant tamoxifen but not toremifene: A single institution expericence | |
| Lan, Bo; Ma, Fei; Fan, Ying; Zhai, Xiaoyu; Xu, Binghe | |
| 2018 | |
| 卷号 | 78期号:4 |
| ISSN号 | 0008-5472 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6360473 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Lan, Bo,Ma, Fei,Fan, Ying,et al. CYP2D6*10 genotype was associated with worse outcome of premenopausal breast cancer patients receiving adjuvant tamoxifen but not toremifene: A single institution expericence[J],2018,78(4). |
| APA | Lan, Bo,Ma, Fei,Fan, Ying,Zhai, Xiaoyu,&Xu, Binghe.(2018).CYP2D6*10 genotype was associated with worse outcome of premenopausal breast cancer patients receiving adjuvant tamoxifen but not toremifene: A single institution expericence.,78(4). |
| MLA | Lan, Bo,et al."CYP2D6*10 genotype was associated with worse outcome of premenopausal breast cancer patients receiving adjuvant tamoxifen but not toremifene: A single institution expericence".78.4(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论